Welcome to LookChem.com Sign In|Join Free

CAS

  • or

453566-14-8

Post Buying Request

453566-14-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

453566-14-8 Usage

General Description

3-Bromo-5-cyanobenzoic acid is a chemical compound with the molecular formula C8H4BrNO2. It is a white to off-white crystalline powder that is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. 3-Bromo-5-cyanobenzoic acid is known for its ability to act as a building block in the production of various organic molecules, and it is also used in the development of new drugs and other biologically active compounds. 3-Bromo-5-cyanobenzoic acid is considered to be a versatile and important chemical in the field of medicinal chemistry and organic synthesis, and it is widely used in research and development within the pharmaceutical and chemical industries.

Check Digit Verification of cas no

The CAS Registry Mumber 453566-14-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,5,3,5,6 and 6 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 453566-14:
(8*4)+(7*5)+(6*3)+(5*5)+(4*6)+(3*6)+(2*1)+(1*4)=158
158 % 10 = 8
So 453566-14-8 is a valid CAS Registry Number.

453566-14-8Relevant articles and documents

BENZOPYRAZOLE COMPOUND USED AS RHO KINASE INHIBITOR

-

Paragraph 0535-0537; 0617-0620, (2021/02/25)

The invention relates to a benzopyrazole compound used as RHO kinase inhibitor, a pharmaceutical composition and uses thereof for preparing an RHO kinase inhibiting drug, and more specifically to said compound of formula (I-1), a pharmaceutically acceptable salt and isomer thereof.

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

-

, (2008/06/13)

The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 453566-14-8